DIBUCAINE CHOLINESTERASE - ANVISA Registration 80146502233
Access comprehensive regulatory information for DIBUCAINE CHOLINESTERASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502233 and manufactured by SENTINEL CH. SPA. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including SENTINEL CH.SPA, ROCHE DIAGNOSTICS GMBH, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80146502233
25351454939201950
56998701000116
Company Information
Dates and Status
Nov 18, 2019
VIGENTE
09/18/2025 19:00:01
DIBUCAINE CHOLINESTERASE
Dibucaine CHE
SENTINEL CH.SPA
80146501806
Jul 23, 2012
DIBUCAINE CHOLINESTERASE
DIBU (Dibucain)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411475
Feb 10, 2020
CHOLINESTERASE
CHED2-CHOLINESTERASE/DIBUCAINE GEN.2
ROCHE DIAGNOSTICS GMBH
10287410741
Jul 14, 2008
CHOLINESTERASE
Alinity c Cholinesterase
SENTINEL CH. SPA
80146502249
Mar 16, 2020
CHOLINESTERASE
ADVIA CHEMISTRY CHOLINESTERASE REAGENTS (CHE)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345160630
Jul 30, 2007